Form 4 for CVSA Covista Inc.
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-13 · accession 0001127602-24-027258 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-13 | 2024-11-13 | CVSA | O'KEEFE SHARON | Dir | A - Grant | $89.85 | +1,560 | 15.2K | +11% | +$140.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-13 | A | A | 1,560 | $89.85 | 15,152 | D | — | — | (F1) The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date. (F2) The number of restricted stock units awarded to the Reporting Person was determined by dividing the total dollar value of director compensation awarded to the Reporting Person by $89.85, the closing price of ATGE common stock on November 13, 2024. |